| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus aureus (FAD 209P JC-1) |
- |
- |
12.5 － ? |
Miloxacin  |
1439 |
| Staphylococcus aureus (FAD 209P JC-1) |
- |
- |
>100 － ? |
Nalidixic acid (NegGam) |
1439 |
| Staphylococcus aureus (FAD 209P) |
>- |
>200 |
? － ? |
Idebenone |
823 |
| Staphylococcus aureus (FAD 209P) |
- |
- |
3.13 － ? |
FNQ13 |
257 |
| Staphylococcus aureus (FAD 209P) |
- |
- |
64 － ? |
1,4-dihydroxy-2-naphthoic acid |
824 |
| Staphylococcus aureus (FDA 209P + methicillin-susceptible) |
- |
- |
0.063 － ? |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
397 |
| Staphylococcus aureus (FDA 209P + methicillin-susceptible) |
- |
- |
0.063 － ? |
Minocycline (Minocycline hydrochloride, Minocin) |
397 |
| Staphylococcus aureus (FDA 209P + methicillin-susceptible) |
- |
- |
0.125 － ? |
Levofloxacin (Levaquin, Quixin) |
397 |
| Staphylococcus aureus (FDA 209P + methicillin-susceptible) |
- |
- |
0.5 － ? |
Vancomycin (Vancocyn, Lyphocin) |
397 |
| Staphylococcus aureus (FDA 209P + methicillin-susceptible) |
- |
- |
2 － ? |
Ceftriaxone (Rocephin) |
397 |
| Staphylococcus aureus (FDA 209P + pH 6.0) |
- |
- |
0.39 － ? |
Carbenicillin (Pyopen, Geogen, Geocillin) |
616 |
| Staphylococcus aureus (FDA 209P + pH 6.0) |
- |
- |
3.13 － ? |
SCE-129 |
616 |
| Staphylococcus aureus (FDA 209P + pH 7.0) |
- |
- |
0.39 － ? |
Carbenicillin (Pyopen, Geogen, Geocillin) |
616 |
| Staphylococcus aureus (FDA 209P + pH 7.0) |
- |
- |
3.13 － ? |
SCE-129 |
616 |
| Staphylococcus aureus (FDA 209P + pH 8.0) |
- |
- |
0.78 － ? |
Carbenicillin (Pyopen, Geogen, Geocillin) |
616 |
| Staphylococcus aureus (FDA 209P + pH 9.0) |
- |
- |
0.78 － ? |
Carbenicillin (Pyopen, Geogen, Geocillin) |
616 |
| Staphylococcus aureus (FDA 209P + pH 9.0) |
- |
- |
6.25 － ? |
SCE-129 |
616 |
| Staphylococcus aureus (FDA 209P) |
- |
- |
0.008 － ? |
Sitafloxacin |
332 |
| Staphylococcus aureus (FDA 209P) |
- |
- |
0.016 － ? |
DU-6856 |
332 |
| Staphylococcus aureus (FDA 209P) |
- |
- |
0.016 － ? |
Imipenem |
349 |
| Staphylococcus aureus (FDA 209P) |
- |
- |
0.063 － ? |
DU-6857 |
332 |
| Staphylococcus aureus (FDA 209P) |
- |
- |
0.25 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
332 |
| Staphylococcus aureus (FDA 209P) |
- |
- |
0.25 － ? |
Levofloxacin (Levaquin, Quixin) |
332 |
| Staphylococcus aureus (FDA 209P) |
- |
- |
0.25 － ? |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
349 |
| Staphylococcus aureus (FDA 209P) |
- |
- |
0.39 － ? |
Carbenicillin (Pyopen, Geogen, Geocillin) |
616 |
| Staphylococcus aureus (FDA 209P) |
- |
- |
0.39 － ? |
Carbenicillin (Pyopen, Geogen, Geocillin) |
616 |
| Staphylococcus aureus (FDA 209P) |
- |
- |
0.39 － ? |
Carbenicillin (Pyopen, Geogen, Geocillin) |
616 |
| Staphylococcus aureus (FDA 209P) |
- |
- |
0.39 － ? |
Carbenicillin (Pyopen, Geogen, Geocillin) |
616 |